Fund Holdings — MPM ASSET MANAGEMENT LLC

Total Portfolio Value
$182.09M
Total Bought
$0
Total Sold
$42.88M
Net Transaction
-$42.88M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
iTeos Therapeutics, Inc.2,738,7852,738,785037,35740,64422.32%+3,287
Entrada Therapeutics, Inc.(TRDA)4,425,7844,425,784062,71363,06734.64%+354
Repare Therapeutics, Inc.2,242,6362,242,636010,5637,4014.06%-3,162
Adaptimmune Therapeutics plc(ADAPY)5,555,4615,555,46108,7785,4172.97%-3,361
Werewolf Therapeutics, Inc.(HOWL)4,284,1724,284,172027,76110,4535.74%-17,308
Dyne Therapeutics, Inc.(DYN)3,451,3031,561,496-1,889,80797,98255,10530.26%-42,877
Page 1 of 1
MPM ASSET MANAGEMENT LLC — 13F Holdings — Q2 2024 | TickerTrail